ArticleFrontiers in immunology2025

BTG2-deficient mast cells remodel the tumor and tumor-draining lymph node microenvironment leading to chemotherapy resistance in breast cancer.

Xiaoqian Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.